The burgeoning TDP-43 therapeutics market is projected to reach $250 million by 2025, experiencing a significant CAGR driven by increasing ALS and FTD prevalence. Learn about market trends, key players (Biogen, ImStar, etc.), and future growth projections in this in-depth analysis.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.